Skip to main content

Table 1 Epidemiologic characteristics and association with positive serology

From: Schistosoma and Strongyloides screening in migrants initiating HIV Care in Canada: a cross sectional study

Characteristic

Number (%)

Positive† Schistosoma serology

Positive† Strongyloides serology

Number (%)

OR (95% CI)

p-value

Number (%)

OR (95% CI)

p-value

Sex

 Female

88 (34.78)

17 (19.32)

1.00 (referent)

 

4 (4.54)

1.10 (.23–4.48)

1.00#

 Male

164 (64.82)

30 (18.29)

.96 (.49–1.85)

.890

7 (4.27)

.91 (.22–4.36)

1.00#

Age

  < 30

40 (15.81)

5 (12.50)

0.97 (.31–2.98)

0.961

0 (0.00)

–

–

 30- < 40

94 (37.15)

12 (12.77)

1.00 (referent)

–

7 (7.45)

3.08 (.76–14.76)

0.13#

 40- < 50

80 (31.62)

21 (26.25)

2.50 (1.13–5.50)

0.023

1 (1.25)

.21 (.0048–1.52)

0.18#

  > 50

39 (15.42)

9 (23.08)

2.31 (.87–6.12)

0.092

3 (7.69)

2.17 (.35–9.60)

0.45#

Diagnosis HIV

 New

77 (30.56)

11 (14.29)

.61 (.39–1.27)

0.185

1 (1.30)

.22 (.0049–1.58)

0.20#

 Established

175 (69.44)

36 (20.57)

1.00 (referent)

–

10 (5.71)

4.61 (.64–203.55)

0.20#

ART treatment

 Active ART

134 (52.96)

20 (14.93)

1.00 (referent)

 

6 (4.48)

1.00 (referent)

–

 No current ART

119 (47.04)

27 (22.69)

1.55 (.82–2.95)

0.183

5 (4.20)

0.92 (.27–3.10)

0.900

Immigration status

 Citizen

69 (28.75)

11 (15.94)

0.74 (0.32–1.64)

0.56#

1 (1.45)

.30 (.0067–2.28)

0.416#

 Permanent Resident

134 (55.83)

30 (22.39)

1.70 (0.82–3.66)

0.169#

6 (4.48)

1.63 (0.34–10.29)

0.743#

 Temporary resident

37 (15.42)

4 (10.81)

0.52 (0.13–1.62)

0.354#

2 (5.41)

1.60 (0.156–8.902)

0.831#

Refugee status*

 Non refugee

206 (81.42)

30 (14.56)

1.00 (referent)

–

8 (3.89)

0.59 (0.13–3.59)

0.66#

 Refugee

47 (18.58)

17 (36.17)

3.55 (1.72–7.33)

0.001

3 (6.38)

1.70 (0.28–7.45)

0.66#

Region of origin

 Africa

145 (57.54)

40 (27.59%)

6.15 (2.44–18.60)

0.000#

9 (6.21)

3.50 (0.704–34.01

0.16#

 Latin America

36 (14.29)

2 (5.56)

0.25 (.028–1.06)

0.065#

1 (2.78)

0.60 (.013–4.45

1.00#

 North America

10 (3.97)

2 (20.00)

1.03 (.103–5.41)

1.000#

0 (0.00)

–

 

 Other

4 (1.59)

0 (0.00)

–

–

1 (25.00)

7.64 (.14–105.60)

0.33#

 Asia

57 (22.62)

2 (3.51)

0.12 (.14–.51)

0.0006#

0 (0.00)

–

–

  1. N total = 253. The number of observations are listed for each category with percentage in brackets. †Positive serology refers to all non-negative serology results. #Exact logistic regression was used for analyses with cell counts less than 5. Odds ratios (ORs) are listed for each comparison with 95% confidence intervals (CI) in brackets. Bolded CIs and p-values are statistically significant. *Refugees included those that were Government assisted, privately sponsored, refugee claimants and refugees otherwise unspecified.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us